FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Bruno Lawrence 2. Date of Event Requiring Statement (Month/Day/Year) 02/08/2018 3. Issuer Name and Ticker or Trading Symbol CORE LABORATORIES N V [CLB] (Last) (First) (Middle) 6316 WINDFERN ROAD 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) President 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) HOUSTON, TX 77040 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Shares 4,287 D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Shares	  (1)	  (1)	Common Shares	600	$ (1)	D	Â
Performance Shares	  (2)(3)	  (2)(3)	Common Shares	5,400	$ (2) (3)	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Bruno Lawrence 6316 WINDFERN ROAD HOUSTON, TX 77040	Â	Â	  President	Â

Signatures

/s/ Mark Elvig, Attorney-in-Fact		02/08/2018
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Restricted Shares vest in the amount of 1/6th of the grant on each of the six annual anniversaries following the respective grant date. Mr. Bruno has three grants still outstanding, and of those the following shares remain unvested at this time: 200 shares from the grant on 08/01/12; 100 shares from the grant on 09/01/12; and 300 shares from the grant on 04/01/14.
(2)	Assuming his continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, 3,000 shares would vest at the end of a three-year performance period that began on January 1, 2016 and ends on the last NYSE trading day of December 2018 (the "2016 Performance Period"). 3,000 of the restricted Performance Shares will vest only upon the Company's return on invested capital being in the top decile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the 2016 Performance Period. If this criteria is not met, then no shares shall vest and the award shall be forfeited.
(3)	Assuming his continued employment (or death or disability while employed) and the satisfaction of certain performance goals is achieved, 2,400 shares would vest at the end of a three-year performance period that began on January 1, 2017 and ends on the last NYSE trading day of December 2019 (the "2017 Performance Period"). 2,400 of the restricted Performance Shares will vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the 2017 Performance Period. If this criteria is not met, then no shares shall vest and the award shall be forfeited.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.